Antibody-mediated rejection in liver transplantation: Current controversies and future directions

Timucin Taner; Mark D. Stegall; Julie K. Heimbach

doi:10.1002/lt.23826

Antibody-mediated rejection in liver transplantation: Current controversies and future directions

Timucin Taner, Mark D. Stegall, Julie K. Heimbach

Transplant Surgery

Research output: Contribution to journal › Review article › peer-review

40 Scopus citations

Abstract

Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.

Original language	English (US)
Pages (from-to)	514-527
Number of pages	14
Journal	Liver Transplantation
Volume	20
Issue number	5
DOIs	https://doi.org/10.1002/lt.23826
State	Published - May 2014

ASJC Scopus subject areas

Surgery
Hepatology
Transplantation

Access to Document

10.1002/lt.23826

Cite this

@article{d4994ee76a554fdfb5c0ac661e832400,

title = "Antibody-mediated rejection in liver transplantation: Current controversies and future directions",

abstract = "Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.",

author = "Timucin Taner and Stegall, {Mark D.} and Heimbach, {Julie K.}",

year = "2014",

month = may,

doi = "10.1002/lt.23826",

language = "English (US)",

volume = "20",

pages = "514--527",

journal = "Liver Transplantation",

issn = "1527-6465",

publisher = "John Wiley and Sons Ltd",

number = "5",

}

TY - JOUR

T1 - Antibody-mediated rejection in liver transplantation

T2 - Current controversies and future directions

AU - Taner, Timucin

AU - Stegall, Mark D.

AU - Heimbach, Julie K.

PY - 2014/5

Y1 - 2014/5

N2 - Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.

AB - Interest in the role of donor-specific human leukocyte antibodies in liver transplantation has been rekindled recently. Emerging evidence suggests that these antibodies may cause injury to the liver allograft. Here we review the clinical literature, highlight controversial results, and propose a path forward for the definition and better understanding of antibody-mediated injury to the liver.

UR - http://www.scopus.com/inward/record.url?scp=84899658205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899658205&partnerID=8YFLogxK

U2 - 10.1002/lt.23826

DO - 10.1002/lt.23826

M3 - Review article

C2 - 24470340

AN - SCOPUS:84899658205

SN - 1527-6465

VL - 20

SP - 514

EP - 527

JO - Liver Transplantation

JF - Liver Transplantation

IS - 5

ER -

Antibody-mediated rejection in liver transplantation: Current controversies and future directions

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this